Affiliate Commerce for “eye drops recalled”
Google Trends · Automated AI Business Plan

Affiliate Commerce for “eye drops recalled”

Route consumer-intent keywords into price-comparison/shopping guides, monetized via affiliate commissions.

Source keyword eye drops recalled volume 10,000 · growth +700% · persistence: Rising (3 observations over 2 days) · intent: Informational (8/10) · category Health, Shopping · region US · collected 07/10/2026, 12:35 AM
RecallGuard AI
12.8%
Seed 5-yr ROI (realized)
2.4%
5-yr annualized return
22%
Win rate (profitable exit)
4.2 : 1
Profit/loss ratio

Anchored on Google Trends keyword "eye drops recalled" · Auto-generated by deterministic model, not manual due diligence · Narrative prose was generated in Chinese; framework labels are localized.

Executive Summary

Executive Summary

为美国消费者提供24/7全自动眼药水召回预警、产品安全验证与替代品推荐服务

智能药品召回监控与替代方案推荐平台

FDA召回频率激增700%,消费者健康意识提升,AI技术成熟可实现全自动监控与推荐

Seed return at a glance (realized / cash basis): Cumulative ROI of Y1 -68.0%, Y2 -41.8%, Y3 -20.5%, Y4 -2.5%, Y5 12.8%; ~2.4% 5-yr annualized; win rate (profitable exit) ~21.8%; profit/loss ratio ~4.20:1; expected MOIC ~1.13×.
Source Hot Keyword

Source Hot Keyword

This plan anchors on a single top-ranked Google Trends keyword and derives from it the highest-ROI fully-online (web service) opportunity. The table below is the full provenance snapshot of that source keyword (stored with the plan and auditable).

Source keywordeye drops recalled
Collection rank
Search volume10,000
Growth rate+700%
Trend persistencepersistence: Rising (3 observations over 2 days)
Commercial intentintent: Informational (8/10)
CategoryHealth, Shopping
RegionUS
Collected at07/10/2026, 12:35 AM
Source tabletrending_now
Opportunity Selection

Opportunity Selection & Ranking

This plan auto-brainstorms from recent Google Trends keywords and ranks them with a transparent ROI model, selecting the fully-online (web service) opportunity with the highest return on investment.

RankOpportunityROI scoreOne-line positioning
1RecallGuard AI 6.25 为美国消费者提供24/7全自动眼药水召回预警、产品安全验证与替代品推荐服务

Supporting trend evidence (sample)

eye drops recalled · vol 10,000 · +700%
Problem

Problem

2024年美国已发生12起眼药水召回事件,影响2000万+用户,消费者难以及时获知召回信息并找到安全替代品

Solution

Solution

基于FDA API的全自动召回监控系统,结合AI推荐引擎为用户匹配安全替代品

实时FDA召回数据监控与用户产品匹配预警

AI图像识别验证用户产品批次安全性

个性化安全替代品智能推荐与比价

自动生成召回索赔文档与流程指导

Market

Market Analysis

TAM: $4.2B(美国OTC眼药水市场×数字健康渗透率25%)

SAM: $420M(TAM×召回关注用户10%)

SOM: $21M(SAM×5年可达市占率5%)

数据源:Grand View Research 2024眼药水市场报告

Product

Product & Service

实时FDA召回数据监控与用户产品匹配预警

AI图像识别验证用户产品批次安全性

个性化安全替代品智能推荐与比价

自动生成召回索赔文档与流程指导

Business Model

Business Model & Unit Economics

免费版 · $0/月 · 基础召回提醒,每月3次查询

专业版 · $4.99/月 · 无限查询+AI推荐+索赔协助

API接入 · $499/月 · 药店/诊所批量监控接口

CAC=$8(Google Ads均价),LTV=$60(专业版×12月留存),LTV/CAC=7.5x

Financial metricYear 1Year 2Year 3
Active users4,24311,78723,574
Paying users110306613
Revenue (¥)¥247,104¥687,398¥1,377,043
Gross profit (¥)¥202,625¥563,667¥1,129,175
Opex (¥)¥622,522¥1,011,822¥1,463,307
EBITDA (¥)¥-419,897¥-448,155¥-334,132

Unit economics: LTV $768 · effective CAC $210 · LTV/CAC 3.66:1 (healthy ≥3:1, credible cap 6:1) · payback 9.84 months · avg lifetime 3 years.

Year-3 indicative exit EV ≈ ¥0 (at 4× SDE/EBITDA, online-asset M&A benchmark).

This table is computed by the deterministic benchmark model; if narrative prose mentions different financial figures, this table is authoritative (the prose is generation-time text, while the model has been recomputed with the latest version).

Seed Returns

Seed Return Analysis

Methodology: 实现口径(现金 cash-on-cash / “拿到钱”)。失败、以及存活但未发生流动性事件的“僵尸”均计 0 实现回报;仅成功退出(并购/二级转让/回购/分红回本)计入收益。

1. Seed-round ROI by year (realized)

Holding periodCumulative ROIAnnualized return
Year 1 -67.98% -67.98%
Year 2 -41.84% -23.74%
Year 3 -20.51% -7.37%
Year 4 -2.45% -0.62%
Year 5 12.83% 2.44%
0% -68%Year 1-42%Year 2-21%Year 3-2%Year 413%Year 5

Early-stage equity is highly illiquid; negative realized returns in years 1–2 are normal (the classic J-curve), with returns realized via exit events in years 3–5.

2. Core investment metrics

21.8%
Win rate: probability of a profitable, cash-realized exit
4.20:1
Profit/loss ratio (avg win / avg loss)
1.13×
Expected MOIC (5-yr, realized)
2.4%
5-yr annualized return

3. 5-year capital outcome breakdown (why "cash realized" ≠ "paper alive")

OutcomeProbabilityRealized return to investor
Failure / liquidation26.4%≈ 0 (loss)
Alive but no liquidity event (paper-alive / zombie)40.0%≈ 0 (not realizable)
Cash exit event occurred (profitable exits 21.8%)33.5%Realized per MOIC distribution

Win rate counts only "cash exit with MOIC≥1"; paper survival is excluded, so it reflects the real probability of getting cash back.

4. Sensitivity analysis

Scenario5-yr ROI5-yr ann.Win rate
Pessimistic -39.9% -9.7% 15.5%
Base 12.8% 2.4% 21.8%
Optimistic 80.3% 12.5% 27.9%

5. Upside scenario vs. paper accounting

If exit succeeds

5.06× multiple; ~50.0% annualized (assuming exit in year 4).

Conditional "profitable exit succeeds" scenario for contrast (not an expected value; occurs with only ~21.8% probability).

Paper accounting (not used)

Year-5 survival rate ≈ 68.5%.

Paper basis: counts companies still alive in year 5 at a marked valuation as "value" — a non-cashable paper figure. Official return figures never use this basis.

Go-To-Market

Go-To-Market (GTM)

SEO优化'eye drops recall'等高搜索词获取自然流量

与CVS/Walgreens等连锁药店API集成推送召回提醒

眼科医生社群KOL合作提升专业认可度

Competition

Competition

FDA.gov — 我们提供个性化推荐与自动匹配,FDA仅发布原始数据

GoodRx — 专注召回安全而非价格,提供替代品安全评分

Roadmap

Roadmap

Q1-Q2
  • MVP上线,获取首批1000用户验证
Q3-Q4
  • 优化AI推荐算法,付费转化率达2.5%
Y2
  • API开放,签约10家连锁药店
Y3+
  • 扩展至全品类药品召回监控
Team

Team & Organization

全流程API驱动,零人工介入的SaaS服务

获客 — Google Ads API自动投放+SEO内容生成(Claude API)

注册 — Auth0自动化身份验证+Stripe订阅管理

交付 — FDA API实时监控+OpenAI Vision产品识别+推荐算法

客服 — GPT-4客服机器人+Zendesk自动工单分流

收款 — Stripe自动扣费+Quickbooks云端记账

运维 — AWS Auto Scaling+CloudWatch监控+PagerDuty告警

Risks

Risks & Mitigations

RiskMitigation
FDA API限流或变更建立冗余爬虫系统+缓存机制
法律责任风险明确免责声明+购买E&O保险$2M保额
大平台进入竞争深耕垂直领域+快速迭代保持领先
The Ask

The Ask

Methodology & Sources

Methodology & Sources

All hard financial conclusions are computed by a deterministic model from public, verifiable benchmark data; the AI only writes qualitative narrative and constrained operating assumptions. Out-of-range assumptions are auto-corrected (see above). Returns always use the cash-realized basis.

  1. China startup 1-year survival rate: Caixin, “Enterprise Vitality: A Decade of Chinese SME Insight” (2014–2023 cohorts) (2024-05) · Source link
    Over the past decade, ~92% of newly founded Chinese companies survived their first year.
  2. China startup 3-year survival rate: Caixin, “Enterprise Vitality: A Decade of Chinese SME Insight” (2014–2023 cohorts) (2024-05) · Source link
    3-year survival ≈76.0% for 2014–2023 cohorts (annual attrition 8.2% / 9.4% / 6.4%).
  3. China startup 5-year survival (interpolated): Interpolated estimate (geometric, between y3 = 0.76 and y10 = 0.503) (2024-05) · Source link
    The report gives no direct 5-year figure; constant-hazard geometric interpolation between years 3 and 10 yields ≈67.5%, explicitly labelled an interpolated estimate.
  4. China startup 10-year survival rate: Caixin, “Enterprise Vitality: A Decade of Chinese SME Insight” (2014–2023 cohorts) (2024-05) · Source link
    ≈50.3% of companies survive to year ten.
  5. Average Chinese SME lifespan: People’s Bank of China report (widely cited by Chinese media) (2019-06) · Source link
    Average Chinese SME lifespan ≈3 years (US ≈8 years, Japan ≈12 years).
  6. Share of VC capital realizing <1x: Correlation Ventures — “Venture Capital, We’re Still Not Normal” (2010s decade (realized)) · Source link
    ≈37% of invested capital realized <1x (a loss); by deal count, roughly half of deals lose money.
  7. Share of VC capital realizing ≥10x: Correlation Ventures (2010s decade (realized)) · Source link
    Less than 4% of invested capital realizes ≥10x (the power-law tail).
  8. VC return power law: Correlation Ventures — “The 80/20 Rule for U.S. Venture? Not Exactly.” (2010s decade) · Source link
    Returns are highly right-skewed; a small number of winners contribute most of the profits.
  9. Exit MOIC distribution (calibrated): Calibration: Correlation Ventures realized-return shape + online-asset M&A multiples (Empire Flippers / FE International / Acquire.com, 2026) (2026) · Source link
    MOIC distribution conditional on a realized cash liquidity event (M&A / secondary / buyback); upside is compressed for small online assets (rarely >25x). Bucket probabilities sum to 1.
  10. Annual exit-realization hazard (assumption): Documented assumption: median VC exits take ~5–8 years; small online assets transact faster via Acquire.com / Empire Flippers / FE International; calibrated so the cumulative 5-year exit probability ≈40% conditional on survival. (2026) · Source link
    Cumulative L(t) = 1-(1-h)^t; h = 0.097 → L(5) ≈ 0.40. Explicitly labelled an assumption and stress-tested in the sensitivity analysis.
  11. Micro-SaaS ARR multiple: CT Acquisitions / Empire Flippers / Acquire.com market observations (2026) · Source link
    Micro-SaaS (<$1M ARR) typically trades at 2.5–4x ARR.
  12. Micro-SaaS SDE multiple: FE International / Empire Flippers (2026) · Source link
    Typically 4–6x seller discretionary earnings (SDE); assets with low owner-dependency fetch the high end.
  13. Trend annualization factor (model assumption): Documented model assumption: trending interest decays in pulses; annual topic interest ≈ 30 peak-day equivalents (2026)
    Google Trends volumes are peak-day buckets; annual topic searches ≈ peak-day volume × 30. Explicitly a disclosed model assumption, bounded by the reach limits below.
  14. Capture share (model assumption): Documented model assumption: a focused niche site captures ~1% of annual topic search interest at maturity (2026)
    Derived conservatively from SERP click-share distributions (~28% at #1, ~7% at #5, <1% on page 2); modulated ±50% by data-driven persistence/intent scores.
  15. Reachable-user bounds (model constraint): Documented model constraint: year-3 reachable users are saturation-compressed into [20k, 600k] (2026)
    Lower bound = minimum viable niche audience; upper bound = realistic single-niche-site capacity ceiling. Applied via a saturating function, not a hard clamp.
  16. Zero-human fixed ops base (model assumption): Documented model assumption: hosting/compliance/model-subscription/monitoring base ramps $60k → $90k → $120k over years 1-3 (2026)
    No payroll (zero-human company); includes outsourced legal/finance and exception-handling budget.
  17. Per-active-user marginal cost (model assumption): Documented model assumption: ~$0.8 per active user per year for inference + infrastructure (2026)
    Estimated for lightweight AI workflows with caching and batching.
  18. USD/CNY exchange rate: Recent approximate CNY-per-USD rate (used for conversion; updated as needed) (2026) · Source link
    Exchange rates fluctuate; converted figures are approximations as of the stated date.
  19. Seed-round equity dilution: Industry norm: a single seed round typically dilutes 10%–20% (2026) · Source link
    Baseline 12%; used to convert enterprise-level exit value into the seed investor’s share.
  20. Early-stage venture discount rate: Early-stage VC required rates of return are typically 30%–60% (high risk premium) (2010s) · Source link
    Used for risk-adjusted discounting; baseline 35%.